-->

Tests and diagnosis

Fertility Diagnostic Tests in LahoreComprehensive Clinical Guide, WHO Parameters & Cost Transparency

What are Fertility Diagnostic Tests?

Fertility diagnostic tests are a targeted battery of clinical laboratory investigations, hormonal assays, and specialized imaging procedures designed to evaluate both male and female reproductive health. A complete fertility assessment includes a WHO 6th Edition semen analysis and sperm DNA fragmentation index (DFI) for men, alongside Anti-Müllerian Hormone (AMH) testing, baseline gonadotropin panels (FSH, LH, Estradiol), transvaginal ultrasound antral follicle count (AFC), and tubal patency screening (HSG or HyCoSy) for women. At Kamran Fertility Clinic in Lahore, diagnostic evaluation is conducted with clinical restraint—ordering only medically necessary tests to identify the precise root cause of subfertility without imposing unneeded financial burden.

Where tests fit in your fertility journey

An assessment is the full evaluation of each partner. Tests are the individual investigations used within it. Your diagnosis is the conclusion Dr. Kamran explains once the results are in, and it decides which treatment makes sense.

  1. AssessmentHistory, examination and plan for each partner
  2. TestsThe investigations on this page
  3. DiagnosisExplained in your results consultation
  4. TreatmentIUI, IVF, ICSI and more, only if needed

Fertility tests at a glance

Every test on this page, who it is for, and when it needs to be done.

TestForTimingResults
Semen analysis (WHO 6th Ed.)Male2–5 days abstinenceWithin 24 hours
Sperm DNA fragmentation (DFI)Male2–5 days abstinence2–3 working days
Semen culture & sensitivityMaleWhen infection signs are present—
Male hormonal panelMaleSevere oligo/azoospermiaWithin 24 hours
AMH (ovarian reserve)FemaleAny day of the cycle2–3 working days
FSH, LH, Estradiol, TSH, ProlactinFemaleFSH/LH/E2 on cycle day 2 or 3Within 24 hours
Ovulation trackingFemaleAcross the cycle—
HSG or HyCoSy (tubal patency)FemaleCycle days 6–10Same visit

Individual guides: Semen analysis, Hormonal analysis and Ovulation tracking.

1. The Clinical Importance of Purposeful Fertility Diagnostics

Achieving conception requires a synchronized sequence of biological events: mature egg release, adequate sperm count and motility, patent fallopian tubes, and a receptive uterine lining. When a couple experiences difficulty conceiving after 12 months of regular, unprotected intercourse (or 6 months if the female partner is aged 35 or older), systematic diagnostic testing is essential.

At Kamran Fertility Clinic, Dr. Kamran Saleem approaches reproductive diagnostics with strict medical integrity. Rather than subjecting couples to exhaustive, repetitive, or non-evidence-based testing panels, our diagnostic strategy is guided by three core principles:

Targeted Investigation

Diagnostic tests are selected based on medical history, physical evaluation, and clinical indications—ensuring every investigation yields actionable diagnostic value.

Dual-Partner Concurrent Testing

Male and female partners are evaluated simultaneously from the first consultation, recognizing that male factor subfertility contributes to approximately 40% to 50% of all reproductive challenges.

Diagnostic Precision First

Establishing an accurate diagnosis before initiating treatment prevents costly, unnecessary interventions and allows for personalized protocol selection (e.g., distinguishing candidates for Ovulation Induction/IUI from those requiring ICSI or Micro-TESE).

Who should not wait for the 12-month mark

Book an earlier consultation if the woman is 40 or older, periods are very irregular or absent, or there is a history of PCOS, endometriosis, pelvic infection or surgery, repeated miscarriage, cancer treatment, or a previous abnormal semen analysis. If you are planning fertility preservation, see Egg & Sperm Freezing.

2. Male Fertility Diagnostic Suite: WHO 6th Edition Standards & Advanced Sperm Testing

Male reproductive health requires accurate, standardized laboratory evaluation. As a specialist holding a UK Diploma in Genito-Urinary Medicine (GUM) & Venereology from the University of Liverpool, Dr. Kamran Saleem provides specialized expertise in evaluating sperm function, reproductive tract infections, and male endocrine disorders. Start with the Male Fertility Assessment.

  1. Step 1: WHO 6th Ed Semen AnalysisVolume, Concentration, Motility, Strict Kruger Morphology
  2. Step 2: Advanced Sperm DFISCSA/TUNEL Assay for Chromatin Integrity & Oxidative Damage
  3. Step 3: Male Hormonal & Scrotal DopplerSerum Testosterone, FSH, LH & Varicocele Ultrasound Evaluation

A. Semen Analysis (WHO 6th Edition Laboratory Manual Standards)

Semen analysis remains the cornerstone of male fertility evaluation. Our diagnostic laboratory adheres strictly to the WHO 6th Edition (2021) guidelines, utilizing standardized counting chambers and Kruger strict morphology criteria. Read the full semen analysis guide.

Semen ParameterWHO 6th Edition Reference LimitClinical Significance & Diagnostic Interpretation
Semen Volume≥ 1.4 mLLow volume (< 1.4 mL) indicates ejaculatory duct obstruction, retrograde ejaculation, or congenital absence of vas deferens (CBAVD).
Sperm Concentration≥ 16 million/mLConcentrations below 16 M/mL indicate Oligozoospermia; absence of sperm indicates Azoospermia.
Total Sperm Number≥ 39 million/ejaculateReflects overall testicular sperm production capacity.
Total Motility (PR + NP)≥ 42%Percentage of moving sperm; values below 42% indicate Asthenozoospermia.
Progressive Motility (PR)≥ 30%Sperm moving actively in a forward direction; essential for unassisted tubal migration.
Normal Kruger Morphology≥ 4.0% strict normal formsStructural integrity of sperm head, midpiece, and tail; values < 4% indicate Teratozoospermia.
Vitality (Live Sperm)≥ 54% membrane intactDifferentiates live immotile sperm from dead sperm in severe asthenozoospermia cases.
Leukocyte Count (WBCs)< 1.0 million/mLElevated white blood cells (> 1.0 M/mL) indicate Leukocytospermia (active reproductive tract infection or inflammation).

B. Sperm DNA Fragmentation Index (DFI) Testing

Standard semen analysis evaluates sperm count and movement but does not assess genetic material integrity. Sperm DNA Fragmentation Index (DFI) measures single- and double-strand DNA breaks within the sperm head using advanced assays (SCSA, TUNEL, or Sperm Chromatin Dispersion).

Normal DFI (< 15%)

High genetic integrity; excellent prognosis for natural conception, IUI, and conventional IVF.

Moderate DFI (15% to 30%)

Mild to moderate chromatin damage; lifestyle modification, antioxidant therapy, and varicocele treatment advised.

High DFI (> 30%)

Significant DNA damage linked to recurrent unexplained IVF/ICSI fertilization failure, poor blastocyst development, and early pregnancy loss. Indicates the need for specialized sperm selection techniques (PICSI/IMSI) or testicular sperm extraction (TESA). See ICSI.

C. Semen Culture & Sensitivity Testing

Given Dr. Kamran Saleem’s specialized background in Genito-Urinary Medicine, semen culture testing is performed whenever leukocytospermia, altered semen pH, or symptoms of urogenital infection are detected. Identifying and treating subclinical bacterial infections (such as Ureaplasma, Mycoplasma, or E. coli) with targeted antibiotics restores sperm motility and prevents infection transmission.

D. Male Reproductive Hormonal Panel & Scrotal Doppler Ultrasound

When severe oligozoospermia or azoospermia is diagnosed, secondary blood testing and imaging are performed:

  • Serum Testosterone, FSH, LH, and Prolactin: Differentiates Obstructive Azoospermia (OA) (normal hormones, physical blockage) from Non-Obstructive Azoospermia (NOA) (elevated FSH/LH indicating primary testicular failure, or low FSH/LH indicating hypogonadotropic hypogonadism).
  • Scrotal Color Doppler Ultrasound: Evaluates testicular volume, detects epididymal cysts or vas deferens absence, and identifies subclinical varicoceles (dilated scrotal veins that elevate testicular temperature and impair spermatogenesis).

E. Genetic Tests for Severe Male Factor

When a man has azoospermia or a very low sperm count, a genetic blood test may be advised before treatment. A karyotype checks the chromosomes, and a Y-chromosome microdeletion test looks for missing segments that control sperm production. If the vas deferens is absent (CBAVD), CFTR gene testing is considered. These results affect what is possible with surgical sperm retrieval and whether embryo genetic testing (PGT) is worth discussing.

3. Female Fertility Diagnostic Suite: Ovarian Reserve, Hormones & Pelvic Imaging

Female reproductive diagnostics evaluate ovarian egg quantity and quality, ovulatory regularity, fallopian tube patency, and uterine cavity receptivity. Start with the Female Fertility Assessment.

  1. Phase 1: Ovarian Reserve & Basal HormonesAMH Blood Test + Day 2/3 FSH, LH & E2
  2. Phase 2: Tubal Patency ScreeningHSG X-Ray or 3D/4D HyCoSy Scan
  3. Phase 3: Pelvic Ultrasound & OvulationTransvaginal Ultrasound (AFC & Cavity)

A. Ovarian Reserve Evaluation (AMH, Basal Hormones & AFC)

Assessing ovarian reserve provides vital prognostic insight into a woman's remaining egg supply and expected response to fertility medications. Read the full hormonal analysis guide.

Serum Anti-Müllerian Hormone (AMH): AMH is produced by small antral follicles in the ovaries and can be tested on any day of the menstrual cycle (unaffected by hormonal contraceptives or cycle phase).

Optimal Reserve (1.5 to 4.0 ng/mL)

Normal egg supply; predicts good response to Ovulation Induction and IVF stimulation.

High Reserve (> 4.0 to 7.0+ ng/mL)

Characteristic of Polycystic Ovary Syndrome (PCOS); requires low-dose stimulation protocols to prevent Ovarian Hyperstimulation Syndrome (OHSS). See Ovulation Induction & PCOS.

Diminished Ovarian Reserve (DOR) (< 1.0 ng/mL)

Reduced egg quantity; indicates the need for timely intervention and individualized stimulation protocols.

Cycle Day 2 or 3 Basal Hormonal Panel

  • Follicle-Stimulating Hormone (FSH) & Luteinizing Hormone (LH): Basal FSH > 10–12 IU/L suggests declining ovarian responsiveness; an LH-to-FSH ratio > 2:1 is indicative of PCOS.
  • Serum Estradiol (E2): Baseline estrogen levels < 50 pg/mL confirm ovarian quiescence prior to starting stimulation.
  • Antral Follicle Count (AFC) via Transvaginal Ultrasound: Performed on Cycle Day 2, 3, or 4 to physically count visible 2mm–10mm resting follicles in both ovaries. An AFC of 10 to 20 total antral follicles reflects healthy reserve.

B. Ovulation Tracking

Ovulation tracking confirms whether, and when, you release an egg. Depending on your cycle, it can combine cycle charting, home LH kits, and the mid-luteal progesterone blood test described below. It is also used to time IUI and to monitor response during ovulation induction. Read the full ovulation tracking guide.

C. Fallopian Tube Patency & Pelvic Screening (HSG & HyCoSy)

Unobstructed, healthy fallopian tubes are required for natural conception and IUI, as fertilization takes place within the ampullary region of the tube.

Hysterosalpingogram (HSG)

A specialized diagnostic fluoroscopic X-ray performed between Cycle Days 6 and 10. Radio-opaque contrast dye is gently instilled through the cervix into the uterine cavity, taking real-time images as the dye fills the uterus, flows through the fallopian tubes, and spills into the peritoneal cavity. HSG confirms tubal patency and identifies uterine cavity abnormalities (such as endometrial polyps, submucosal fibroids, or uterine septa).

Hysterosalpingo-Contrast Sonography (HyCoSy)

An advanced, comfortable 3D/4D transvaginal ultrasound alternative that uses a specialized microbubble foam contrast agent to visualize tubal flow without X-ray radiation exposure.

D. Endocrine, Ovulatory & Metabolic Screening

  • Day 21 Serum Progesterone (Mid-Luteal Phase): Tested 7 days prior to anticipated menstruation (Day 21 of a 28-day cycle). A value > 10 ng/mL confirms successful ovulation and adequate luteal phase corpus luteum function.
  • Serum Thyroid-Stimulating Hormone (TSH) & Prolactin: Subclinical hypothyroidism (TSH > 2.5 mIU/L) or hyperprolactinemia (elevated prolactin) directly interferes with pulsatile GnRH secretion, causing anovulation or luteal phase defect.
  • Fasting Insulin & Glucose Ratio: Evaluates insulin resistance in women with PCOS, guiding targeted metabolic treatment with Metformin or Myo-Inositol.

E. Pre-Treatment Screening

Before IUI, IVF or ICSI, the clinic may also check blood group, blood count, rubella immunity, and screening for HIV, hepatitis B, hepatitis C and syphilis in both partners, and other tests such as vitamin D only where clinically indicated. This protects you, your partner and any future pregnancy, and is part of safe treatment rather than a search for the cause of infertility.

4. Patient Preparation Guidelines & Test Execution Protocol

To ensure absolute accuracy and prevent test invalidation, patients should follow standardized preparation instructions:

Male Preparation Guidelines (Semen Analysis & DFI)

  • Abstinence Window: Strictly 2 to 5 days of ejaculatory abstinence prior to sample collection. Abstinence periods < 2 days may artificially lower sperm volume and count; abstinence > 5 days leads to sperm accumulation, reduced motility, and increased DNA fragmentation.
  • Collection Protocols: Samples are collected on-site in dedicated, private collection suites across our DHA Defence, Gulberg, or Shalamar clinics into sterile, non-toxic containers.

Female Preparation Guidelines (Bloods, Imaging & HSG)

  • Basal Hormone Testing: Serum FSH, LH, and Estradiol MUST be drawn strictly on Cycle Day 2 or 3 of natural menstrual bleeding.
  • AMH Testing: Can be drawn on any calendar day regardless of menstrual cycle phase.
  • HSG / HyCoSy Procedure Window: Scheduled strictly between Cycle Days 6 and 10 (after menstrual bleeding has completely stopped, but prior to ovulation) to ensure the uterine lining is thin and prevent accidental disruption of an early unconfirmed pregnancy.

5. Diagnostic Decision Matrix & Treatment Matching

Following comprehensive diagnostic evaluation, Dr. Kamran Saleem analyzes all findings during a dedicated 45–60 minute consultation to map out an evidence-based treatment pathway:

Diagnostic Findings ProfilePrimary Female FindingsPrimary Male FindingsRecommended Clinical Pathway
Normal Diagnostic ProfileNormal AMH, patent tubes (HSG), regular ovulatory cycles.Normal WHO parameters (TMSC > 15M, Motility > 42%, DFI < 15%).Expectant Management or 3–6 cycles of Ovulation Induction + Timed Intercourse. Learn more
Mild Female Anovulation / Mild Male FactorPCOS / Anovulation, normal tubal patency.Mild Oligo/Asthenozoospermia (TMSC 10M–15M).3–4 cycles of Ovulation Induction + Intrauterine Insemination (IUI). Learn more
Bilateral Tubal BlockageOccluded fallopian tubes on HSG/HyCoSy, normal/diminished reserve.Normal or mild male factor.In Vitro Fertilization (IVF) (bypasses fallopian tubes entirely). Learn more
Severe Male Factor InfertilityNormal or variable ovarian reserve.Severe Oligo/Astheno/Teratozoospermia (TMSC < 5M, DFI > 30%).Intracytoplasmic Sperm Injection (ICSI) or PICSI/IMSI. Learn more
Azoospermia (Zero Sperm in Ejaculate)Normal ovulatory function and reserve.Complete absence of ejaculated sperm.Hormonal evaluation + Surgical Sperm Retrieval (Micro-TESE / TESA) combined with ICSI. Learn more

If tests show no clear cause, the diagnosis is unexplained infertility. This is common and does not mean treatment will fail. Dr. Kamran will go through the options with you, including IUI and IVF. You can also bring your reports for a second opinion.

6. Itemized Fee Transparency & Diagnostic Package Guidelines in Lahore

At Kamran Fertility Clinic, financial transparency is a foundational value. Diagnostic pricing is fully disclosed prior to testing:

  • Individual Test Guidelines: Semen analysis, individual hormone assays (AMH, TSH, Prolactin), and pelvic ultrasounds carry fixed, transparent fee structures.
  • Comprehensive Diagnostic Bundles: Bundled male and female diagnostic panels offer cost savings compared to ordering tests individually.
  • No Unnecessary Tests: Dr. Kamran Saleem orders only tests that directly inform clinical decision-making, ensuring patients do not spend money on redundant or non-validated investigations.

7. Frequently Asked Questions (FAQ)

Q1: How soon can we expect semen analysis and blood test results?

At Kamran Fertility Clinic, routine WHO 6th Edition semen analysis and basal hormonal test results (FSH, LH, Prolactin, TSH) are typically available within 24 hours. Advanced testing such as Sperm DNA Fragmentation Index (DFI) and AMH results are processed within 2 to 3 working days.

Q2: Is a Hysterosalpingogram (HSG) tubal X-ray painful?

Most women experience mild to moderate lower abdominal cramping during contrast injection, similar to menstrual cramps, lasting for 5 to 10 minutes. Taking a mild prescribed analgesic 30 to 45 minutes prior to the procedure significantly reduces discomfort. Our clinic also offers HyCoSy ultrasound screening as a comfortable alternative.

Q3: Why is AMH considered a superior marker for ovarian reserve compared to FSH?

FSH levels fluctuate significantly from month to month and must be tested strictly on Cycle Day 2 or 3. In contrast, Anti-Müllerian Hormone (AMH) is continuously produced by small antral follicles, maintaining stable serum concentrations throughout the menstrual cycle. AMH provides a highly reliable, consistent reflection of total remaining ovarian egg supply.

Q4: Can a single abnormal semen analysis confirm male infertility?

No. Sperm production (spermatogenesis) operates on a 74-day cycle and is sensitive to recent illnesses, fever, emotional stress, medications, or heat exposure. If an initial semen analysis shows abnormal parameters, Dr. Kamran Saleem recommends repeating the test after 2 to 4 weeks with strict 2–5 days abstinence to confirm clinical findings.

Q5: Do both partners need to be tested?

Yes. Male and female partners are evaluated together from the first consultation, because male factor contributes to roughly 40% to 50% of fertility challenges. Testing only one partner can leave the real cause undiscovered.

Q6: Do I need every test on this page?

No. Tests are chosen from your history and examination, and only those that change your treatment decision are ordered. Most couples need a small core set: semen analysis, AMH with basal hormones, and a tubal check.

Q7: Which test is done on which day of the cycle?

Semen analysis can be done any day after 2–5 days of abstinence. AMH can be drawn on any day. FSH, LH and Estradiol are drawn on cycle day 2 or 3. HSG or HyCoSy is done on days 6 to 10. Mid-luteal progesterone is drawn about 7 days before your expected period.

Q8: When should we see a specialist?

After 12 months of trying, or after 6 months if the woman is 35 or older. Do not wait if the woman is 40 or older, if cycles are very irregular or absent, or if there is a known history of PCOS, endometriosis, pelvic infection, pelvic surgery, repeated miscarriage, or a previous abnormal semen analysis.

10. Schedule Your Unhurried Consultation with Dr. Kamran Saleem

Accurate fertility diagnosis begins with a dedicated, compassionate consultation focused entirely on your health history and reproductive goals.

Dr. Kamran Saleem provides unhurried, 45 to 60-minute initial consultations to review prior reports, order targeted investigations, and explain diagnostic findings with complete transparency.

  1. Step 1: Unhurried Consult45–60 min review with doctor
  2. Step 2: Targeted TestingWHO 6th Ed Semen / AMH / HSG
  3. Step 3: Clear Medical PlanHonest diagnostic review & options

How to Schedule Your Diagnostic Visit

Direct Consultation Booking: Contact Kamran Fertility Clinic via WhatsApp.

Clinic Facilities Across Lahore

  • DHA Defence: Rasheed Hospital (Phase 5/6)
  • Gulberg III: TAMC Clinic, M.M. Alam Road
  • Shalamar: Shahnaz Hospital, Link Road

What to Bring: Please bring any prior medical records, ultrasound scans, semen analysis reports, or blood test results to your appointment for a thorough clinical review.

This page is for general information and is not a substitute for medical advice. Reference ranges are guides, and your results are interpreted together with your history and examination. Fees, availability and turnaround times may change; please confirm with the clinic.